Table 1 Preoperative characteristics
No anticoagulation (n = 100) | Warfarin or NOAC (n = 56) | p-value | |
|---|---|---|---|
Patent false lumen | 79 (79%) | 48 (86%) | 0.39 |
Age (years) | 61.9 ± 9.3 | 59.0 ± 13.3 | 0.01 |
Female | 27 (27%) | 17 (30%) | 0.71 |
Hypertension | 52 (52%) | 23 (41%) | 0.19 |
Thoracic aneurysm | 9 (9%) | 5 (9%) | 1 |
Marfan | 7 (7%) | 5 (9%) | 0.67 |
Other connective disease | 1 (1%) | 1 (2%) | 1 |
BAV | 2 (2%) | 2 (4%) | 0.62 |
PVD | 1 (1%) | 1 (2%) | 1 |
DM | 25 (25%) | 8 (14%) | 0.12 |
Hyperlipidemia | 5 (5%) | 2 (4%) | 1 |
Stroke | 4 (4%) | 2 (4%) | 1 |
CKD | 1 (1%) | 1 (2%) | 1 |
COPD | 7 (7%) | 1 (2%) | 0.26 |
CAD | 6 (6%) | 1 (2%) | 0.42 |
Smoking history | 30 (30%) | 14 (25%) | 0.48 |
BMI | 26.1 ± 3.9 | 27.1 ± 4.5 | 0.18 |
Betablocker | 18 (18%) | 8 (14%) | 0.52 |
ACE inhibitor | 29 (30%) | 8 (14%) | 0.03 |
Systolic blood pressure (mmHg) | 127 ± 35 | 118 ± 32 | 0.18 |
Diastolic blood pressure (mmHg) | 72 ± 21 | 65 ± 17 | 0.08 |